MedPath

Dysregulated Urea-synthesis at Terminal Uremia

Not Applicable
Recruiting
Conditions
Urea Cycle Disorder
Uremia
Registration Number
NCT05076318
Lead Sponsor
University of Aarhus
Brief Summary

This project will examine the dysregulation of the urea cycle in patients with terminal uremia using a validated method named "Functional Hepatic Nitrogen Clearance"

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Age > or equal to 18 years
  • Chronic hemodialysis during 3 months
  • Patients with functioning arteriovenous-fistula assigned to "Center-Hemodialysis" at "Nyresygdomme, AUH Skejby"
Exclusion Criteria
  • Active infection
  • Conditions with vomiting or diarrhea
  • Diabetes
  • Active disease being treated with chemotherapy, radiationtherapy, biologic- or similar treatments. Disease under observation can be included.
  • Liver disease
  • Vessels on the upper extremities not suited for cannulation
  • Prednisolone treatment during the last 8 weeks
  • Pregnancy
  • BMI > or equal to 30 or < or equal to 18
  • Physically or mentally condition that does not allow the project to be completed
  • Language-difficulties that does not allow the project to be completed

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Urea synthesis rate during alanine infusion4 hours. 1 hour of blood sample measuring of baseline urea-synthesis rate and 3 hours of urea-synthesis rate during alanine-infusion

Change in the synthesis of urea during a 3 hour period of alanine-infusion in pre and post hemodialysis patients. We will use a validated method named functional hepatic nitrogen clearance (FHNC) to evaluate the synthesis of urea. FHNC is calculated using the linear relation between urea nitrogen synthesis rate and blood-amino acid which is measured every hour. An estimated group of 10 dialysis patients will be included and compared to a clinical healthy group. The healthy group has also received alanine infusion and blood samples of urea and amino-acids has likewise been measured for every hour of infusion.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Aarhus

🇩🇰

Aarhus N, Denmark

University Hospital Aarhus
🇩🇰Aarhus N, Denmark
Rasmus Eriksen, MD
Contact
30264691
raerik@rm.dk

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.